EVIMED 60 (Raloxifene HCL) belongs to a category of medicine referred to as selective estrogen receptor modulators-SERMs. is employed by women to stop and treat bone loss (osteoporosis) after menopause. It slows down bone loss and helps to stay bones strong, making them less likely to interrupt.
EVIMED 60 can also lower the prospect of getting a particular sort of carcinoma after menopause.
(USD)
